Phase I Study of SPH1188-11 in NSCLC
Clinical trial NCT03231475 · WITHDRAWN
Trial details
- NCT number
- NCT03231475
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-21
- Primary completion
- 2020-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.